As we approach almost 12 months from the government’s Patient Capital Review, there have been challenges and regulatory changes, but I’m pleased to say that this sector remains a thriving, interesting and importantly an entrepreneurial environment – and particularly one that is creating British jobs, as well as providing excellent investment opportunities.
The EIS/SEIS market has seen some incredible ventures and exits this year; VCTs continue to be an amazing and often oversubscribed investment; and BR, SITR and other tax efficient investments continue to be a successful solution to both estate and tax planning.
